Cover Image
市場調查報告書

過敏診斷的全球市場 ∼2022年:診斷套件,免疫學的檢測法 & ELIZA分析設備,光度計,服務

Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 321266
出版日期 內容資訊 英文 151 Pages
訂單完成後即時交付
價格
Back to Top
過敏診斷的全球市場 ∼2022年:診斷套件,免疫學的檢測法 & ELIZA分析設備,光度計,服務 Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022
出版日期: 2017年08月31日 內容資訊: 英文 151 Pages
簡介

過敏診斷的全球市場,預計從2017年到2022年以10.5%的年複合成長率(CAGR)擴大到57億4000萬美元規模。市場成長的主要推動因素,是過敏疾病患者的增加,加上環境污染的擴大,醫療費的增加,美國的醫療保險制度改革等。各產品中,預計化驗套件今後將急速成長。

本報告提供過敏診斷的全球市場為焦點,產品與服務,過敏原 (過敏誘發物質),檢驗方法,終端用戶,地區的各分類的變化預測,市場現狀,發展的影響要素,競爭環境,主要企業等最新的調查、分析資訊彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 主要考察

  • 過敏診斷市場概要
  • 過敏診斷市場:各過敏原
  • 過敏診斷市場地區概要
  • 過敏診斷市場:各檢驗類型

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動要素
      • 過敏疾病的發病率高和經濟負擔重
      • 環境污染的擴大
      • 醫療費擴大
    • 阻礙因素
      • 對小規模診斷的診斷所及診療所來說高額的設備設備
      • 對過敏疾病的認識度低
    • 機會
      • 亞太地區及其他地區(RoW)的成長機會
    • 趨勢
      • 自動化的引進縮短診斷的時間
      • 檢驗試劑出租契約的登場

第6章 過敏診斷市場:產品 & 各類服務

  • 簡介
  • 診斷套件
  • 診斷設備
  • 免疫檢測分析設備
    • 光度計
    • ELISA (酵素結合免疫吸附法) 分析設備
    • 其他
  • 服務

第7章 過敏診斷市場:各檢驗法

  • 簡介
  • 生物內 (in vivo) 檢驗
  • 體外 (in vitro) 檢驗

第8章 過敏診斷市場:各過敏原

  • 簡介
  • 吸入過敏原
  • 食品過敏原
  • 藥物過敏原
  • 其他過敏原

第9章 過敏診斷市場:各終端用戶

  • 簡介
  • 診斷測試所
  • 醫院
  • 學術研究機關
  • 其他

第10章 過敏診斷市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲各國
  • 亞洲
    • 中國
    • 日本
    • 印度
    • 其他亞洲各國
  • 其他地區 (ROW)
    • 南美
    • 太平洋、大洋洲
    • 中東、非洲

第11章 競爭環境

  • 簡介
  • 市場佔有率分析
  • 龍頭製圖
  • 競爭基準

第12章 企業簡介

  • 簡介
  • THERMO FISHER SCIENTIFIC INC.
  • SIEMENS AG
  • DANAHER CORPORATION
  • OMEGA DIAGNOSTICS GROUP PLC
  • 日立化成
  • BIOMERIEUX SA
  • STALLERGENES GREER
  • HOB BIOTECH GROUP SUZHOU CO., LTD.
  • HYCOR BIOMEDICAL, INC.
  • LINCOLN DIAGNOSTICS, INC.
  • R-BIOPHARM AG

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 2955

The global allergy diagnostics market is expected to reach USD 5.74 billion by 2022, at a CAGR of 10.5% from 2017 to 2022. The major factors driving this market are the high incidence and large economic burden of allergic diseases, rising environmental pollution levels, increasing healthcare expenditure, and growing access to medical insurance in the US. On the other hand, the growth of this market is hindered to some extent due to the limited awareness about allergy diagnosis in some developing countries.

Assay kits to register the highest CAGR during the forecast period

The allergy diagnostics market is classified on the basis of product & service into assay kits, instruments, and services. The assay kits segment is expected to grow at the highest rate during the forecast period. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.

Diagnostic laboratories to dominate the allergy diagnostics market during the forecast period

The allergy diagnosis market is segmented based on end users into diagnostic laboratories, hospital-based laboratories, academic & research institutes, and other end users. In 2017, the diagnostic laboratories segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to other segments. The market is mainly driven by the increasing incidence of allergic disorders in emerging countries.

Asia is estimated to be the fastest growing regional segment in the market during the forecast period

Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asian region is estimated to grow at the fastest rate which can be attributed to the improving life sciences research infrastructure in emerging economies and rising investments by governments to promote research activities.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 70% and Tier 2 - 30%
  • By Designation - C-level - 62%, Director Level - 21%, Others - 17%
  • By Region - North America - 20%, Europe - 30%, Asia - 50%

The key players in the market are Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMerieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abello A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd. (Singapore), Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), and Demeditec Diagnostics GmbH (Germany).

Study Coverage:

The report analyses the allergy diagnostics market by product and service, test, allergen, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the type, products, test, end users, and regions.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the allergy diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the allergy diagnostics market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the allergy diagnostics market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various allergy diagnostic products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the allergy diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Primary sources
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ALLERGY DIAGNOSTICS: MARKET OVERVIEW
  • 4.2. ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS (2017)
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE ALLERGY DIAGNOSTICS MARKET
  • 4.4. ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2017 VS. 2022

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High incidence and large economic burden of allergic diseases
      • 5.2.1.2. Rising environmental pollution levels
      • 5.2.1.3. Increasing healthcare expenditure
      • 5.2.1.4. Increasing access for allergy diagnosis medical insurance in the US
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Issues related to the affordability of allergy diagnostics instruments among small laboratories and physician clinics
      • 5.2.2.2. Low awareness of allergic diseases
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging economies across Asia and RoW
    • 5.2.4. TRENDS
      • 5.2.4.1. Growing adoption of automation for quicker turnaround times
      • 5.2.4.2. Growth in the number of reagent rental agreements

6. ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. ASSAY KITS
  • 6.3. INSTRUMENTS
    • 6.3.1. IMMUNOASSAY ANALYZERS
    • 6.3.2. LUMINOMETERS
    • 6.3.3. ELISA ANALYZERS
    • 6.3.4. OTHER INSTRUMENTS
  • 6.4. SERVICES

7. ALLERGY DIAGNOSTICS MARKET, BY TEST

  • 7.1. INTRODUCTION
  • 7.2. IN VIVO TESTS
  • 7.3. IN VITRO TESTS

8. ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN

  • 8.1. INTRODUCTION
  • 8.2. INHALED ALLERGENS
  • 8.3. FOOD ALLERGENS
  • 8.4. DRUG ALLERGENS
  • 8.5. OTHER ALLERGENS

9. ALLERGY DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. DIAGNOSTIC LABORATORIES
  • 9.3. HOSPITAL-BASED LABORATORIES
  • 9.4. ACADEMIC RESEARCH INSTITUTES
  • 9.5. OTHER END USERS

10. ALLERGY DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD
    • 10.5.1. LATIN AMERICA
    • 10.5.2. PACIFIC AND OCEANIA
    • 10.5.3. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE LEADERSHIP MAPPING
    • 11.3.1. VISIONARY LEADERS
    • 11.3.2. INNOVATORS
    • 11.3.3. DYNAMIC DIFFERENTIATORS
    • 11.3.4. EMERGING COMPANIES
  • 11.4. COMPETITIVE BENCHMARKING
    • 11.4.1. STRENGTH OF PRODUCT PORTFOLIO (25 PLAYERS)
    • 11.4.2. BUSINESS STRATEGY EXCELLENCE (25 PLAYERS)

Top 25 companies analysed for this study are - Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd (Japan), bioMerieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abello A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd, Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), Demeditec Diagnostics GmbH (Germany)

12. COMPANY PROFILES (Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy)*

  • 12.1. THERMO FISHER SCIENTIFIC INC.
  • 12.2. SIEMENS AG
  • 12.3. DANAHER CORPORATION
  • 12.4. OMEGA DIAGNOSTICS GROUP PLC
  • 12.5. HITACHI CHEMICAL CO., LTD.
  • 12.6. BIOMERIEUX SA
  • 12.7. STALLERGENES GREER
  • 12.8. HOB BIOTECH GROUP SUZHOU CO., LTD.
  • 12.9. HYCOR BIOMEDICAL, INC.
  • 12.10. LINCOLN DIAGNOSTICS, INC.
  • 12.11. R-BIOPHARM AG

*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: ALLERGY DIAGNOSTICS MARKET SUMMARY
  • TABLE 2: HEALTHCARE EXPENDITURE, BY COUNTRY, 2005-2014 (USD BILLION)
  • TABLE 3: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 4: ALLERGY DIAGNOSTICS ASSAY KITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR IMMUNOASSAY ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR LUMINOMETERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET FOR ELISA ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: OTHER ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: ALLERGY DIAGNOSTICS SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 13: IN VIVO ALLERGY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: IN VITRO ALLERGY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 16: INHALED ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: FOOD ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: DRUG ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: OTHER ALLERGENS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 21: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 31: US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 32: US: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 33: US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 34: US: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 35: CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 36: CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 37: CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 38: CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 41: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 42: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 43: EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 44: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 45: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 46: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 47: GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 48: UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 49: UK: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 50: UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 51: UK: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 52: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 53: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 54: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 55: FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 56: ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 57: ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 58: ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 59: ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 61: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 62: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 63: SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 64: ROE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 65: ROE: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 66: ROE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 67: ROE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 68: ASIA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 69: ASIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 70: ASIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 71: ASIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 72: ASIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 73: CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 74: CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 75: CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 76: CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 77: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 78: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 79: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 80: JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 81: INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 82: INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 83: INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 84: INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 85: ROA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 86: ROA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 87: ROA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 88: ROA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 89: ROW: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 90: ROW: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 91: ROW: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 92: ROW: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 93: ROW: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 94: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 95: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 96: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 97: LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 98: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 99: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 100: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 101: PACIFIC AND OCEANIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 102: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 103: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY TEST, 2015-2022 (USD MILLION)
  • TABLE 104: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2015-2022 (USD MILLION)
  • TABLE 105: MIDDLE EAST AND AFRICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL ALLERGY DIAGNOSTICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: ALLERGY DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: ALLERGY DIAGNOSTICS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION
  • FIGURE 7: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: ALLERGY DIAGNOSTICS MARKET, BY ALLERGENS, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 11: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 12: HIGH INCIDENCE AND LARGE ECONOMIC BURDEN OF ALLERGIC DISEASES IS EXPECTED TO DRIVE THE MARKET
  • FIGURE 13: INHALED ALLERGENS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017
  • FIGURE 14: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: IN VIVO TESTS TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET DURING 2017 TO 2022
  • FIGURE 16: ALLERGY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
  • FIGURE 17: ASSAY KITS TO FORM THE LARGEST PRODUCT SEGMENT IN 2017
  • FIGURE 18: IN VIVO TESTS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET DURING 2017-2022
  • FIGURE 19: INHALED ALLERGENS SEGMENT TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017
  • FIGURE 20: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 21: NORTH AMERICA TO DOMINATE THE ALLERGY DIAGNOSTICS MARKET IN 2017
  • FIGURE 22: NORTH AMERICA: ALLERGY DIAGNOSIS MARKET SNAPSHOT
  • FIGURE 23: ASIA: ALLERGY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 24: GLOBAL ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
  • FIGURE 25: ALLERGY DIAGNOSTICS MARKET (GLOBAL): COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 26: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 27: SIEMENS AG: COMPANY SNAPSHOT (2016)
  • FIGURE 28: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 29: OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT (2016)
  • FIGURE 30: HITACHI CHEMICAL CO., LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 31: BIOMERIEUX SA: COMPANY SNAPSHOT (2016)
  • FIGURE 32: STALLERGENES GREER: COMPANY SNAPSHOT (2016)
Back to Top